3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Other hematologic neoplasm
20
Myeloid
11
Thoracic
2
Classical hematology
2
Other solid neoplasm
1
Lymphoid
1
Dermatologic
1
CNS
1
Breast
1
Interventions
lutetium Lu 177 dotatate
14
Specimen Handling
8
Magnetic Resonance Spectroscopy
8
Everolimus
8
cabozantinib
6
pembrolizumab
5
Nivolumab
4
olaparib
3
lenvatinib
3
X-Rays
3
Lutetium-177
3
Cyclophosphamide
3
177Lu-octreotide, DOTA(0)-Tyr(3)-
3
lanreotide
2
gallium Ga 68 dotatate
2
fludarabine phosphate
2
fludarabine
2
avelumab
2
amino-acid, glucose, and electrolyte solution
2
Sunitinib
2
Radiotherapy
2
Phantoms, Imaging
2
Octreotide
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Etoposide
2
Cisplatin
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
telotristat ethyl
1
surufatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
decitabine and cedazuridine drug combination
×
NET
×
90 days
×
Clear all
No trials found.